mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |